To save itself, might Medicare deny coverage of controversial new Alzheimer’s drug?
By
Kimberly Marselas
Jun 28, 2021
The true price to administer aducanumab — a controversial new Alzheimer’s treatment — may actually be closer to $100,000 annually than other, lower estimates and is just one reason the Centers for...
Obama administration boosts Alzheimer’s research with $50 million in funding
Feb 08, 2012
The Obama administration has said it will devote $50 million to fund Alzheimer’s research this year, and an additional $80 million in 2013.
How to better diagnose cognitive health? Up size and variety of drawing tasks, study shows
By
Alicia Lasek (f3)
Jul 01, 2022
Clinicians can more accurately classify a patient’s cognitive health status by increasing the number and variety of diagnostic drawing tasks, investigators report.
Healthy lifestyle behaviors reduce dementia risk regardless of family history, study finds
By
Donna Shryer
May 21, 2021
Healthy lifestyle behaviors lower dementia risk, and that includes those with or without a family history for dementia, preliminary research from the American Heart Association has found.
Algorithm accurately predicts Alzheimer’s risk, study finds
By
Alicia Lasek
May 05, 2020
A computer algorithm can go head-to-head with neurologists, accurately diagnosing Alzheimer’s disease and predicting risk, say investigators.
Largest-ever Alzheimer’s study unlocks new knowledge about the disease’s genetic roots, researchers...
By
Tim Mullaney
Oct 30, 2013
The largest-ever international study of Alzheimer’s disease has significantly expanded the scientific community’s understanding of the disease’s genetic underpinnings, according to a...
Drug cures Alzheimer’s symptoms in mice, Yale researchers find
By
Stephanie H. Kim
Aug 07, 2014
A drug compound successfully reversed the effects of Alzheimer’s disease in mice, researchers say, giving hope to developers trying to find a cure.
Lawmakers should weigh costs associated with dementia when coordinating care for Medicare beneficiaries,...
By
McKnight's Staff
May 17, 2012
As policymakers seek to integrate care for dual eligibles, they need to consider the cost of treating beneficiaries with dementia, new data suggests.
NIA set to build $300M ‘real world’ Alzheimer’s database
By
Alicia Lasek
Apr 06, 2023
The goal is to collect real-world data on Alzheimer’s disease and create a centralized data hub, helping to expand and speed Alzheimer’s research.
Gait speed slows long before dementia diagnosis, 15-year study finds
By
Alicia Lasek
Feb 11, 2022
Slowing gait speed may signal the onset of dementia up to nine years before cognitive decline becomes evident, investigators say. It’s also linked to Alzheimer’s-related brain changes.